University of California, San Diego
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Diego sits in the top decile of US sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count).
University of California, San Diego: 775 sponsored US clinical trials, 143 recruiting.
University of California, San Diego sponsors 775 registered US clinical trials on ClinicalTrials.gov, 143 of them currently recruiting, and 499 completed. 104 of these trials are in Phase 3-4 (later-stage) and 170 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Anorexia Nervosa, with 10 trials.
Top-decile sponsor footprint
University of California, San Diego ranks in the top decile of sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
499 of 553 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
775 total, page 1 of 16
Precision Pain Management - A Randomized Clinical Trial Assessing the Efficacy of Suzetrigine on Postoperative Analgesia Among Surgical Patients at Higher Risk for Persistent Postoperative Opioid Use (POU)
NCT07672015
Culturally Adapted Pain Management for Indigenous Peoples
NCT07524751
Preoperative Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor
NCT07171203
Mindfulness Engaged Neurostimulation for Depression (MEND II)
NCT07512284
Accurate Point of Care Liver Disease Diagnostics (Phase 2)
NCT07518784
Artificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer.
NCT07227233
Behavioral Approach for Latinas Addressing Nutrition, Cravings, and Eating Patterns to Prevent Type 2 Diabetes
NCT07478263
Nutritional Intervention for College Students With Depression
NCT07490782
SB-4826 in Adult Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphomas
NCT07222631
Interpersonal Brain Function in Opioid Use
NCT07386769
Blood Pressure Care for Advancing Real-World Evidence (BPCARE)
NCT07398391
Retifanlimab and Ruxolitinib In Solid Malignancies
NCT07219576
Testing the Effectiveness of an Intervention That Aligns Circadian Rhythm With Daily Activities on Student Flourishing
NCT07410585
Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
NCT06790602
Efficacy of OneMark Device in Identifying Breast Cancer for Surgery and Surveillance
NCT07087691
Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version
NCT07092527
Dance Mental Health App
NCT07219095
Development of PRECISE: A Data Driven Personalized Suicide Prevention Intervention
NCT06809348
Incidence of Long-TeRm Atrial Fibrillation After Acute Illness
NCT07434674
A Randomized Controlled Trial of a Nutritional Intervention for Endometriosis
NCT07090096
Long Term Impact of Time-Restricted Eating on Parameters of Cardiometabolic Health
NCT07189234
Preparedness Through Respiratory Virus Epidemiology and Community Engagement
NCT07147517
Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression: A Home-Based Feasibility and Safety Study
NCT07217223
Neuroimaging and Biomarkers of Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy
NCT07075523
Multivitamin and Mineral Supplementation and Healthy Aging
NCT07642869
Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy
NCT07098169
Cryoneurolysis for Painful Diabetic Neuropathy of the Foot
NCT06646731
Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma
NCT06624475
Implementing Food Referrals for Equity and Sustained Health
NCT06661538
Language Control Across Modalities
NCT07226921
Biological Drivers of Cervical Cancer and Side Effects From Radiation Therapy
NCT07121543
To Test Whether Time-restricted Eating Coupled With a Healthy Diet is Beneficial in Liver Cancer Patients
NCT06824974
Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness (R33)
NCT06865937
Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients
NCT06409819
Image-guided, Tumor-focused Radiotherapy Treatment in Intermediate and High-risk Prostate Cancer
NCT06990542
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
NCT06960317
The Mechanism Versus PPI Trial
NCT06999577
Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy
NCT06586281
Continuous Versus Single Injection Adductor Canal Blocks for Outpatient Total Knee Arthroplasty
NCT06784882
TREAD: Time Restricted Eating Intervention for Alzheimer's Disease
NCT06548191
Tranexamic Acid for Second Trimester Dilation and Evacuation and Bleeding Outcomes
NCT06820177
LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering
NCT06865885
Maintenance rTMS for Depression (Maitr-De)
NCT06938841
Diagnosing Obstructive Sleep Apnea Using Electromyography of the Muscles of the Mouth
NCT06944782
Sleep and Light Intervention (SALI) for Menopausal Mood Dysfunction
NCT06678880
Kawasaki MATCH Trial
NCT07291245
TriCalm Hydrogel® in the Treatment of Immunotherapy-Related Pruritus
NCT06748404
Psilocybin-Assisted Therapy for Physician Well-Being and Burnout
NCT06814522
A Prospective Study of Video-assisted Exercise Program for the Breast Cancer Survivors
NCT07071896
Cryoablation and Arterial Infusion of SD-101 in Combination with Durvalumab and Tremelimumab
NCT06710223
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 80 |
| Phase 2 | 90 |
| Phase 3 | 22 |
| Phase 4 | 82 |
Therapeutic Areas
What is open in the University of California, San Diego pipeline
143 recruiting of 775 indexed (18% open); 499 completed (64%).
Phase mix: 104 late (III/IV) vs 170 early (I/II) (early-phase heavy).
Top condition: Anorexia Nervosa (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Diego: open-pipeline peers nationwide
Peers matched on 775 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University of California, San Diego sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 775 trials (± recruiting share)
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- Medical University of South Carolina · 755 trials · 19% recruiting
- University of Chicago · 796 trials · 20% recruiting
- University of Utah · 818 trials · 17% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Neurocrine Biosciences · 18% recruiting · 65 trials
- Thomas Jefferson University · 18% recruiting · 292 trials
- Abramson Cancer Center at Penn Medicine · 18% recruiting · 402 trials
- University of Maryland, Baltimore · 18% recruiting · 560 trials
Related
What to do with this University of California, San Diego page
775 registered trials is a research-attention snapshot, not an endorsement of University of California, San Diego or any single study.
- 143 of University of California, San Diego's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Anorexia Nervosa is the condition University of California, San Diego studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Anorexia Nervosa trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of California, San Diego pipeline card: 775 registered trials from official public datasets.Report a data error.